|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date † | March 9, 2009 | ||||||||
| Last Updated Date | March 9, 2009 | ||||||||
| Start Date † | October 2007 | ||||||||
| Current Primary Outcome Measures † |
Serological and genetic analysis of biomarkers or genes which are involved in the pathogenesis of COPD. [ Time Frame: 1-2-3 years ] [ Designated as safety issue: No ] | ||||||||
| Original Primary Outcome Measures † | Same as current | ||||||||
| Change History | No Changes Posted | ||||||||
| Current Secondary Outcome Measures † | |||||||||
| Original Secondary Outcome Measures † | |||||||||
| Descriptive Information | |||||||||
| Brief Title † | Serum, Plasma and DNA Bank in Chronic Obstructive Pulmonary Disease | ||||||||
| Official Title † | Serum, Plasma and DNA Bank of Patients With Chronic Obstructive Pulmonary Disease and Smoking Controls. | ||||||||
| Brief Summary | A Plasma, serum and DNA bank together with clinical information including specific questionnaires, complete pulmonary function and chest CT-scan, is prospectivelly collected in patients seen at the investigators' clinical service. The objective is to study candidate gene pathways in COPD and to associate them with the presence and severity of COPD/emphysema. |
||||||||
| Detailed Description | All patients with a smoking history of at least 15 pack years, an minimal age of 50 years and an recent available CT scan are enrolled. In addition we collect:
|
||||||||
| Study Phase | |||||||||
| Study Type † | Observational | ||||||||
| Study Design † | Case Control, Prospective | ||||||||
| Condition † | Chronic Obstructive Pulmonary Disease | ||||||||
| Intervention † | |||||||||
| Study Arms / Comparison Groups | |||||||||
| Publications * | |||||||||
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status † | Recruiting | ||||||||
| Enrollment † | 1000 | ||||||||
| Completion Date | |||||||||
| Primary Completion Date | |||||||||
| Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||||||
| Gender | Both | ||||||||
| Ages | 50 Years and older | ||||||||
| Accepts Healthy Volunteers | Yes | ||||||||
| Contacts †† |
|
||||||||
| Location Countries † | Belgium | ||||||||
| Expanded Access Status | |||||||||
| Administrative Information | |||||||||
| NCT ID † | NCT00858520 | ||||||||
| Responsible Party | Wim Janssens MD. PhD., Katholieke Universiteit Leuven | ||||||||
| Secondary IDs †† | S50623 | ||||||||
| Study Sponsor † | Katholieke Universiteit Leuven | ||||||||
| Collaborators †† | VIB | ||||||||
| Investigators † |
|
||||||||
| Information Provided By | Katholieke Universiteit Leuven | ||||||||
| Verification Date | March 2009 | ||||||||
|
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |
|||||||||
